Recently, EZH2-mediated histone methylation was shown to suppress miR-31 expression in adult T-cell leukemia.26 In this report, we show that EZH2 silences miR-31 in prostate cancer by catalyzing H3K27 trimethylation on the miR-31 promoter. Here, EZH2 is linked to T-cell leukemia.